Search results
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka via Yahoo News· 6 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
Morningstar· 6 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday ...
Kansas sues Pfizer over COVID vaccine development and marketing
BenefitsPRO· 3 days agoPfizer failed to provide adequate information about the vaccine development process and potential...
Merck Wins US Approval for Pneumonia Vaccine to Rival Pfizer’s
Bloomberg· 6 days agoMerck & Co. won US approval for a pneumococcal vaccine that threatens to unseat one of Pfizer Inc.’s...
Kansas Sues Pfizer Over Covid-19 Vaccine’s Safety, Efficacy
Bloomberg Law· 6 days agoThe lawsuit was filed by state Attorney General Kris Kobach in Kansas District Court, Thomas County. Pfizer said its vaccine would prevent the transmission ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 6 days agoPFE, accusing the company of violating consumer protection laws related to its COVID-19 vaccine. Kansas Attorney General Kris Kobach argues that Pfizer ...
Kansas AG Kris Kobach accuses Pfizer of misleading vaccine marketing in lawsuit
Kansas Reflector via Yahoo News· 6 days agoThe state seeks “civil monetary penalties, damages, and injunctive relief from misleading and...
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 6 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products ...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Morningstar· 6 days agoIn a lawsuit filed on Monday, the U.S. state alleges Pfizer made false statements about the safety of its COVID-19 vaccine and then worked to "conceal and ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...